Diabetes, Heart and Cardiovascular Diseases News Chronicle.  Diabetes, Cardiovascular and Heart Diseases
 Article 10
    Published on June 8, 2016


Risks With SSRi

Danish researchers including Morten Wrtz, M.D., Ph.D., from Aarhus University Hospital in Denmark, used a cohort of 12,620 patients and found that 30-day stroke mortality risk in selective serotonin reuptake inhibitors (SSRI) users were 50.7 percent.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Risks With Fine Dust
2. Study Of Liraglutide Drug On Heart Failure

 

 

Treatment For Obesity

UK guidelines recommended surgery for the treatment of obesity which will reduce blood sugar levels. Surgeon Prof Francesco Rubino, Kings College London, says gut operation as "the closest thing to a cure" available and it's a very powerful treatment. The surgery involves removing part of the stomach or rerouting the gut. The operation reduces weight, changes gut hormones and blood sugars will be under control. This operation will eliminate daily usage of drugs and insulin injections.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Biomarkers To Childhood Obesity
2. Device To Predict Diabetes
3. Benefits With Alcohol-Free Blueberry Blackberry Wine

 

 

Guidelines From NICE

National Institute for Health and Care Excellence (NICE) issued final guidelines recommending 3 drugs for use if a person unable to use metformin drug or weight loss therapies are not working. Metformin is the first drug treatment to reduce weight. But some patients experience nausea and diarrhoea (or diarrhea) and some may not able to take the drug as they have kidney damage. Drugs recommended in the guidelines can be considered if they cant take a sulfonylurea or pioglitazone. The following drugs can be used on their own as per NICE guidelines

  • Canagliflozin (Invokana)
  • Dapagliflozin (Forxiga)
  • Empagliflozin (Jardiance)

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. About New Guidelines For Diabetes
2. About NICE Report
3. Benefits With Coffee Consumption

 

 

Devices From Ascensia Diabetes Care

CONTOUR NEXT ONE and CONTOUR PLUS ONE are self-monitoring blood glucose products made by Ascensia Diabetes Care. The products got CE mark approval on May 17, 2016. These are easy to use wireless glucose monitoring systems and links Smartphones via Bluetooth. The patients can asses glucose levels themselves. Apps can be downloaded from Apple App Store (iOS) and Google Play (Android). The new products will be marketed wherever the corresponding test strips are available. Products will be available in two European markets shortly and in other markets by the end of 2016.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Devices From Medtronic
2. About Ascensia Diabetes Care
3. Device To Release Drugs In Eye

 

 

Benefits With Metformin Drug

Researchers from Newcastle University, Queen Elizabeth Hospital, Saudi Arabia found that metformin drug used by diabetes patients will help in preventing heart disease. Researchers constructed a model and simulated a heart attack in a lab. They found blood vessels formation with the usage of metformin drug, which is essential for recovery after heart attack. Lack of oxygen in the presence of high glucose levels delays blood vessel formation and metformin drug will reverse this process and also promote the growth of new blood vessels.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Study With Metformin Drug In Preventing Preterm Birth
2. SR10171 Drug For The Treatment Of Bone Disease And Diabetes
3. Risks To Heart Attack And Diabetes Before Menopause

 

 

Risks With Metformin Drug

Diabetes patients taking metformin drug may get side effects such as weakness, anemia, tingling of fingers and toes. A1C levels too may go low. This may be because of low levels of vitamin B12. Diabetes patient using metformin drug should consult a doctor to check levels of B12 annually.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Risks To Vitamin B12 Deficiency With Metformin
2. Risks To Diabetes Induced Cognitive Impairment
3. Risks With Heart Attack

 

 

Risks With Psoriasis

A Danish study connected psoriasis with type 2 diabetes (T2D) and obesity and suggested a genetic link between them. Dr. Ann Sophie Lonnberg and her team from the University of Copenhagen conducted the study. Researchers examined health records of 33,588 twins registered in the national Danish Twin Registry. Patients may likely suffer from obesity and Type 2 diabetes (T2D) if they have psoriasis. The analysis of this study was published in the journal JAMA Dermatology.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Risks With Adrenal Tumors NFATs
2. About Coronary Heart Disease (CHD)

 

 

Site maps

Site map 1   Site map 2   Site map 3   Site map 4


The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.